RSVPreF3OA vaccine responses in kidney transplant recipients and dialysis patients versus healthy controls
This study provides detailed immunophenotyping of RSVPreF3OA vaccine responses in KTR, DP, and HC over 90 days, showing that RSVPreF3OA vaccination induces protective RSV responses among KTR comparable to HC, while DP mount modestly lower cellular and humoral responses.
Authors
- J. Ritter
- Friederike Bachmann (ORCID: https://orcid.org/0000-0001-7728-9875)
- Annika Wiedemann (ORCID: https://orcid.org/0000-0002-0013-6579)
- Dmytro Khadzhynov
- Hector Julian Rincón-Arévalo
- Andrey Kruglov (ORCID: https://orcid.org/0000-0002-4597-2087)
- Klemens Budde (ORCID: https://orcid.org/0000-0002-7929-5942)
- Fabian Halleck (ORCID: https://orcid.org/0000-0001-9449-2058)
- Dorottya Bőgér
- L.S. Dreveton
- Anna Henning
- Ana-Luisa Stefanski
- Elias Rosenlehner
- Oliver Staeck
- Caterina Carli
- Kai-Uwe Eckardt
- Eva Schrezenmeier
- Thomas Dörner
- Parthenopi Despina Avaniadi
Institutions
- Leibniz Association (DE)
- Universidad de Antioquia (CO)
- German Rheumatism Research Centre (DE)
- KfH Kuratorium für Dialyse und Nierentransplantation (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Nephrology Dialysis Transplantation
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1093/ndt/gfag002
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00